Area of research
Physiology · Molecular Biology
Research interest
Research interests include Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Mitochondrial Function and Pathology, and Computational Drug Discovery Methods.
Amyloid-β and phosphorylated-tau accumulation in retrosplenial cortex of young Alzheimer's disease model: Impact on network activity.
Recommendations for reporting findings from analyses using artificial intelligence and machine learning in the <i>Journal of Alzheimer's Disease</i>.
Plasma biomarkers in neuropsychiatric syndromes: A narrative review.
The Role of Unmethylated 5′-C-Phosphate-G-3′ (CpG) Motifs in Mitochondrial and Bacterial DNA in the Pathogenesis of Alzheimer’s Disease
The Amyloid Cascade Hypothesis: A Conclusion in Search of Support.
Artificial Intelligence in Science and Society: The Vision of USERN
Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study.
Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease Progression, Biomarkers, and Amyloid Deposition.
Conventional and Emerging Drug Targeting Sites in Alzheimer's Disease and the Role of Translational Informatics in its Diagnosis and Management.
Potential Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Diabetes and High Risk for Dementia.
Progesterone induction of tau phosphorylation during the differentiation of human embryonic stem cells into neuroectodermal rosettes.
Hyperphosphorylated Tau Induces Cortical Hypoexcitability in Transgenic Mouse Models: A Meta-Analysis.
Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.
Assessment of X Chromosome Centromere Instability in Alzheimer's Disease: A Quantitative FISH Approach.
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein Aggregates.
Is US residence a risk factor for Alzheimer's disease?
Living the examined life
<i>Ninety-Nine Lessons in Critical Thinking</i>
by Robert FriedlandP.Oxford University Press, 2025, 285 pp.
In data we trust. Book review: “Piller Charles. Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s” PillerCharles (2025).
<i>Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s.</i>
One Signal Publishers/Atria Books, New York, 352 pp. ISBN 978-1-6680-3124-7.
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US.
Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit
Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
The relationship between hippocampal changes in healthy aging and Alzheimer’s disease: a systematic literature review
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease.
Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues.
Central role of brain regulatory T cells in the inflammatory cascade in Alzheimer's disease.
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.
Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease.
Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics.